Research Drops
User Account Blocked by Social Media Platform
Medicaid costs rise with late-stage cancer, study links Medicaid claims to cancer stage and spending patterns, affecting healthcare access.
User Blocked from Social Media Platform
Interstitial lung disease diagnosis is often delayed due to overlapping symptoms with asthma and heart failure, requiring physicians to spot subtle clues…
User Blocked After Repeated Policy Violations
Retatrutide access opens as Eli Lilly launches a compassionate‑use program for patients unable to join clinical trials, awaiting FDA approval soon.
User Blocked After Repeated Violations
Community doula partnership in Erie tackles food insecurity, housing instability, and maternal health gaps, delivering early results and stronger maternity care
User access blocked by platform
Oncologists face insurance delays and logistical hurdles blocking access to advanced cancer treatments like CAR T-cell therapy.
Users Alarmed After Platform Announces Blocking Policy
Vitamin D deficiency linked to kidney disease affects bone health, blood pressure, immune function and survival, revealing a critical public health issue.
Internet users report widespread access blocks
CDC links thousands of Cyclospora outbreak cases to Taco Bell lettuce. Follow the latest updates on the foodborne illness investigation involving Taylor…
User Blocked by Social Media Platform
FDA rejects Capricor's deramiocel for Duchenne muscular dystrophy treatment due to lack of effectiveness evidence, based on phase 3 trial findings.
User blocked from platform after policy breach
A new psoriasis pill, zasocitinib, shows 70% skin clearance rates matching injectable biologics in phase 3 trials. Learn how it compares.
User access restricted after policy breach
The FDA approved Simtriyo, a new ADHD medication for adults and children, improving focus and emotional regulation with extended-release benefits.